| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +30 K | 25% | $6.98 | +$209 K |
| Sells | 5 | -90.2 K | 75% | $14.96 | -$1.35 M |
| Net | -4 | -60.2 K | -50.1% | -$1.14 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Mark J. Foley | CEO, Director | $10.4 M | -$384 K | -3.56% | Jun 30, 2024 |
| Aubrey Rankin | Director | $4.26 M | Mar 15, 2022 | ||
| Dwight Moxie | Clo & Gc | $1.7 M | -$654 K | -27.7% | Mar 15, 2024 |
| Tobin Schilke | Cfo | $1.51 M | -$47.2 K | -3.04% | Jun 30, 2024 |
| Abhay Joshi | COO, President of R&D | $902 K | Mar 15, 2022 | ||
| Dustin S. Sjuts | President | $845 K | -$46.4 K | -5.21% | Mar 15, 2024 |
| David Hollander | CMO & Global Therapeutics Lead | $813 K | Feb 27, 2024 | ||
| Erica Jordan | Chief Commercial Officer | $437 K | -$9.1 K | -2.04% | Apr 16, 2024 |
| Philip J. Vickers | Director | $222 K | May 4, 2022 | ||
| Angus C. Russell | Director | $196 K | May 1, 2024 | ||
| Julian S. Gangolli | Director | $172 K | May 1, 2024 | ||
| Chris Nolet | Director | $166 K | May 1, 2024 | ||
| Jill Beraud | Director | $166 K | May 1, 2024 | ||
| Olivia C. Ware | Director | $120 K | May 1, 2024 | ||
| Carey OConnor Kolaja | Director | $120 K | May 1, 2024 | ||
| Vlad Coric | Director | $79 K | May 1, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|